Alternatives to Qritive

Aiforia provides advanced deep learning and cloud-based solutions to pathologists and researchers in both preclinical and clinical laboratories, enhancing their capabilities in image analysis and workflow efficiency. By enabling scientists to discover new disease biomarkers and assisting R&D professionals in accelerating the market introduction of innovative drugs, Aiforia plays a crucial role in improving cancer diagnostic accuracy while revolutionizing healthcare from the initial discovery phase through to diagnosis. For clinical pathology laboratories seeking to boost efficiency and elevate the precision of their diagnoses, the Aiforia Clinical Suites present a comprehensive range of AI-driven diagnostic tools, intelligent visualization, quality control, and automated pre- and post-screening functionalities. We are in the process of developing specialized Suites targeting some of the most common cancers globally and have achieved CE-IVD certification for our AI solutions in lung and breast cancer, positioning us as a leader in diagnostic innovation. Our commitment to enhancing patient outcomes through technology underscores the transformative potential of our offerings in the healthcare sector.

Paige's offerings have the potential to revolutionize the practice of pathologists by instilling greater certainty in diagnoses. The company is committed to pioneering a new era of clinical tools and predictive assessments that empower pathologists while redefining the field of oncology. With its innovative AI solutions, Paige paves the way for the future of pathology. The Paige Platform serves as a comprehensive, secure solution that ensures interoperability with laboratory information systems (LIS), integrates multiple scanners, offers cloud storage, facilitates case management, enables image review through FullFocus®, and incorporates advanced AI applications. The Paige Prostate suite of AI tools is specifically designed to aid pathologists in identifying suspicious areas, grading and quantifying tissue samples, and assessing perineural invasion (PNI) in prostate needle core biopsies. Similarly, the Paige Breast suite of AI applications supports pathologists in evaluating breast cancer by enabling the identification of malignancies in breast biopsies and the detection of metastases in lymph nodes associated with breast tissue. Collectively, these advancements not only enhance diagnostic accuracy but also improve patient outcomes in oncology.

Concentriq, our advanced AI-driven software platform, operates at the crucial crossroads of digital and computational pathology, merging essential functionalities for routine pathology tasks with robust AI tools that enhance innovations and elevate patient care quality. Pathology laboratories around the globe are acutely aware of the contemporary hurdles, which include an escalating cancer incidence, a shortage of trained pathologists, diminishing reimbursement rates, and the urgent need for modernization. In this context, with one billion pathology slides projected to transition to digital formats annually, generating enormous volumes of new data and insights, the urgency to act is undeniable. Digital pathology equips today’s progressive pathology organizations with the resources necessary to tackle these challenges effectively, thereby revolutionizing our operational methods and significantly impacting the fields of medicine and patient treatment. As this transformation unfolds, the potential for improved diagnostics and enhanced patient outcomes continues to grow exponentially.

Ibex Medical Analytics stands at the forefront of AI-driven cancer diagnostics within the field of pathology. Our diverse team comprises entrepreneurs, data scientists, software engineers, and medical professionals united in our mission to revolutionize cancer diagnostics through artificial intelligence, ultimately enhancing patient care. As the volume of tests continues to rise annually, pathologists face significant challenges in delivering precise and timely analyses. To address this, Ibex harnesses the power of AI to create clinical-grade solutions that aim to identify cancer with the same level of accuracy as a human pathologist. The Galen Platform employs advanced algorithms to scrutinize images, detect and classify cancer in biopsy samples, and highlight other clinically significant findings, thereby assisting pathologists in minimizing diagnostic errors while streamlining their workflow. Notably, Ibex’s Galen™ Prostate and Galen™ Breast solutions represent the pioneering AI-based cancer detection tools integrated into routine clinical practice in pathology labs, showcasing proven efficacy in uncovering previously missed cancer cases. As we continue to innovate, our commitment to improving cancer detection and patient outcomes remains unwavering.

Volpara Health software is utilized by various facilities, including leading cancer screening centers in the United States, to facilitate the early detection of breast cancer. Mammography technologists depend on this software to enhance the quality of mammograms. Recognized as the most scientifically validated screening tool in the breast health sector, Volpara provides essential evidence at critical moments. It offers access to comprehensive patient data, enabling more accurate assessments of breast cancer risk. Each analyzed image contributes to refining our algorithms for early detection of the disease. Your support is crucial in promoting additional screening or genetic tests for patients. The platform allows for the creation of tailored worklists and reports according to individual preferences. Users can simultaneously view statistics and lists from a single interface, making the process more efficient. Communication can be standardized across patients, referrers, and insurers, ensuring clarity and consistency. Furthermore, it enhances the delivery of result letters by incorporating thumbnail images of mammograms, making the information more engaging and informative. This multifaceted approach ultimately promotes better patient care and outcomes in breast health.

The product evaluates a patient's risk level to create a tailored digital screening plan, ensuring more reliable follow-up recommendations and enhancing diagnostic accuracy. This strategy is particularly effective in identifying cancers in women who are at heightened risk. WRRisk integrates a fully digital breast cancer risk assessment that utilizes patient-completed digital forms alongside a density evaluation to generate a comprehensive risk scorecard. By automating numerous manual processes, such as form collection and letter creation, WRRisk streamlines the management of breast risk programs, eliminating the need for paper documentation. This innovative product empowers both patients and healthcare providers with essential information, enhancing the overall care experience. Additionally, WRRisk provides calculations for ten-year and lifetime risk, as well as assessments based on secondary density metrics.

GestPath serves as a comprehensive management system for anatomic pathology procedures, effectively digitizing the entire workflow and addressing the needs of all users involved. By incorporating features such as full traceability, management tools, quality control mechanisms, and security measures at every stage, GestPath enhances the diagnostic process while ensuring standardized task execution. This system not only offers complete oversight for an anatomic pathology department but also contributes to a reduction in operational costs associated with its functions. Additionally, GestPath’s ability to streamline processes aids in improving overall efficiency and accuracy in the pathology field.

Over the past twenty years, collaboration with innovative thinkers has enabled the identification, understanding, and reduction of errors from biopsy to data, resulting in significant advancements in tissue data mining tools, precision, workflow, and automation. Explore the realm of image analysis and tissue mining in both multi and highplexed images, where you can extract clinically significant patterns that provide insights into diseases, transforming your research tissue images into valuable knowledge. Discover the capabilities of CE-IVD APPs and workflows in image analysis, and redefine the approach to standardization through AI-powered pathology solutions that enhance diagnostic decision-making. The app center serves as your entry point to an extensive library filled with AI-driven applications, including those designed to adapt to your specific requirements. Additionally, you can peruse our collection of publications, guides, webinars, and posters to deepen your understanding of digital pathology and see how our software continually supports our clients in their research efforts. Embrace the future of pathology by leveraging these innovative tools and resources to elevate your work and contribute to advancing medical science.

CaseManager DX is an innovative pathology information system aimed at streamlining the entire digital pathology process by consolidating case management, patient records, digital slide integration, and diagnostic reporting into one compliant platform that connects electronic health records and laboratory information systems through HL7 and secure interoperability, catering to both clinical and hospital environments. This system interfaces directly with digital pathology scanners to capture, organize, and archive high-resolution images of histology and cytology slides along with essential clinical and demographic information, allowing pathologists to access comprehensive case details, patient histories, diagnoses, slides, attachments, quantifications, and image analysis results all in one place, while also facilitating standard report writing and clinical documentation. Furthermore, it enhances storage efficiency through SlideStorage DX, provides an intuitive viewing experience with ClinicalViewer, enables teleconsultation for remote collaborative diagnostics, and ensures effective workflow coordination among healthcare professionals. The integration of these features not only improves diagnostic accuracy but also fosters better communication and collaboration within healthcare teams.

AI plays a crucial role in identifying early-stage cancers, facilitating prompt interventions that enhance survival prospects. Cancer's intricate nature means that each type carries distinct characteristics, packed with extensive data that requires thorough analysis. This is where AI excels, leveraging its capabilities to process complex information, ultimately revealing insights that can significantly aid in cancer treatment strategies. Equipped with precise and relevant data, we take proactive steps in our battle against cancer. By utilizing AI, we are poised to make substantial strides in overcoming this disease. Our AI technology is designed to detect early-stage cancer with remarkable accuracy, achieving detection rates between 97-99%. It proficiently identifies ten of the most prevalent abnormalities found in chest x-rays, thus enhancing one of the most fundamental diagnostic tools. This innovation not only streamlines the radiology workflow but also alleviates the workload for radiologists. Lunit INSIGHT CXR successfully encompasses a wide range of findings, ensuring that we are prepared to tackle the challenges presented by cancer detection and treatment. The future of cancer care looks promising with AI at the forefront of these advancements.

Enhancing the care quality and outcomes for individuals battling cancer necessitates a cooperative effort among healthcare providers, researchers, cancer institutions, and the patients themselves. Oncora's user-friendly software platform empowers all parties involved to gather and utilize real-world data, thereby facilitating informed healthcare decisions that prioritize patient welfare. Our solutions are specifically designed for healthcare professionals who are committed to advancing cancer treatment results. By simplifying workflows, alleviating documentation challenges, and optimizing care through smart software solutions, we enable a more efficient healthcare experience. Our intuitive tools allow for the capture and visualization of regulatory-grade real-world data, essential for informed decision-making. With sophisticated reporting capabilities, you can measure quality and enhance operations to elevate patient care. Engaging in rigorous clinical research alongside leading cancer care experts further reinforces our commitment. The intuitive, web-based software we offer is tailored to meet the needs of your cancer center, providing data and tools that expedite clinical breakthroughs and innovations. Ultimately, our mission is to transform cancer care through technology and collaboration, ensuring that patients receive the highest standard of care available.

Techcyte develops innovative machine learning applications specifically for cellular and liquid-based environments, designed to enhance the capabilities of laboratories and professionals in the field of digital diagnostics. Our commitment is to provide comprehensive solutions that offer a seamless and effective user experience at every stage, from sample preparation through to workflow execution and image interpretation, ensuring that we consistently deliver reliable outcomes. We recognize that the most significant breakthroughs in technology and healthcare stem from the ingenuity and dedication of talented individuals. Notably, our Cervical Cytology System serves as a groundbreaking screening instrument, enabling cytotechnologists and pathologists to analyze Hologic ThinPrep® or BD SurePath™ slides with greater efficiency by dramatically minimizing the number of cells they need to assess, all while highlighting the most diagnostically critical cells and organisms through our advanced AI-driven algorithm, optimized laboratory workflows, and integration with Laboratory Information Systems (LIS). This innovative approach not only streamlines the diagnostic process but also elevates the overall quality of patient care.

The integrated mammography viewer allows for ergonomic reading of a diverse range of breast imaging studies alongside other specialty examinations, all conveniently located in one interface. By streamlining workflows, it facilitates quicker reading in high-volume settings, resulting in increased patient throughput. The incorporation of Artificial Intelligence enhances physician efficiency, reduces false negatives in cancer detection, and contributes to the quality assurance of imaging results. A holistic telemammography solution serves as a vital link to expanding access to breast expertise, ultimately leading to improved diagnostic accuracy and patient outcomes. The NovaMG PRO can function as an independent workstation compatible with any PACS or mammography technology. Additionally, the breast care workflow module is included within NovaPACS EI, and current users can activate it in just a few minutes, enhancing their existing systems. This integration not only simplifies the process but also empowers healthcare professionals to deliver better care to patients.

OneLABz is a comprehensive management system designed specifically for pathology labs. This web-based platform streamlines all laboratory operations, ensuring full automation from the moment a sample is collected to the delivery of test results online, via email, or SMS. The Pathology Lab Management System prioritizes efficiency with rapid reporting and electronic medical record capabilities. It features a robust and secure interface that facilitates the management of patient details, doctor and employee registrations, automated chemical stock oversight, and user access controls. Additionally, it tracks lab expenses, collected samples, and generates various reports, ultimately enhancing transparency and profitability. By utilizing this software, pathology labs can significantly reduce costs and improve their overall operational efficiency, ensuring a seamless integration of all lab activities. This innovative solution not only benefits lab staff but also enhances the patient experience by providing timely and accurate results.

Pathology Reporting Software efficiently handles patient records within a Pathology Lab environment. This tool enables the entry of patient test results and generates reports for patients. Additionally, it supports basic accounting functions, such as automating patient billing and calculating doctor incentives. It is designed to cater to the diverse needs of both small and large pathology practices. The software allows for unlimited data storage, utilizing the full capacity of available hard disk space. Users can delete patient records based on date ranges or specific patient codes, and if desired, past records can be permanently removed. Furthermore, it provides the capability to access Patient Test History for reference, making it easier to review previous tests and results for regular clients. Comprehensive reporting features are available for doctors and management information systems, fulfilling all reporting requirements essential for operational management. Moreover, the software allows for simultaneous usage across multiple systems, enhancing efficiency in a collaborative work environment.

Numerous choices in cancer treatment are fraught with uncertainty, and existing resources fail to assist a significant number of patients effectively. As a result, this situation contributes to preventable fatalities and the loss of billions in healthcare expenditures. Our team, which consists of experts from both computer science and oncology, is dedicated to addressing the critical challenges in cancer care using artificial intelligence. We are developing clinical-grade deep learning models that evaluate individual patient profiles and offer valuable guidance to oncologists during their decision-making processes. By placing oncologists at the forefront of our AI development, we ensure that the insights generated are not only interpretable but also actionable. Collaborating with leading academic medical institutions and community oncologists, we aim to tackle important clinical questions to improve patient outcomes. Ultimately, our goal is to enhance decision-making in cancer care and reduce the associated burdens on patients and healthcare systems.

The integration of artificial intelligence is set to revolutionize the field of healthcare diagnosis. By leveraging AI and predictive analytics, we can achieve early detection of diseases and enhance diagnostic accuracy. Our cloud-based AI platform aims to make healthcare more affordable and accessible for everyone. Endimension Technology, a healthcare AI startup fostered at IIT Bombay, specializes in developing advanced algorithms that identify abnormalities and diseases from medical imaging. Our team comprises experts in machine learning, software engineering, and medical professionals from esteemed institutions. We are dedicated to creating AI-driven healthcare solutions that will significantly minimize the incidence of patient misdiagnosis. Furthermore, our technology is designed to alleviate the workload of radiologists while simultaneously improving the speed at which patients receive their results, ultimately leading to better healthcare outcomes. By harnessing the power of AI, we envision a future where diagnostic processes are more efficient and reliable.

Cloud Pathology (CP) is transforming the landscape of diagnostics in the modern era. By leveraging cutting-edge cloud computing technology, it enhances the efficiency of pathology laboratories by an impressive 80%. This innovative system connects seamlessly with all compatible equipment, allowing for streamlined operations. Enjoy a more relaxed lifestyle as Cloud Pathology handles the more demanding tasks, enabling you to oversee processes without stress. It's designed to be the ultimate solution for managing your laboratory needs. Accessible from any device worldwide, pathologists can now review and finalize their reports without the need to rush back to the lab. This advancement not only conserves critical time but also boosts overall efficiency by 35%. Once reports are verified by the responsible physician, they can be automatically dispatched without any manual effort required. Our philosophy prioritizes automation, minimizing human involvement wherever possible. The system is programmed to alert you only when your attention is necessary, ensuring a smooth and efficient workflow. With Cloud Pathology, the future of lab management is not just promising—it's here.

Saral-Path, a pathology laboratory software, allows for fast and easy reporting of all types of pathology tests. Saral Path facilitates Accounting for a pathology lab, such as patient records, referred doctors accounts, centre-wise accounting, and analytical analysis on how improve and expand the lab work. Saral-Path, the company's selling software, gets 75% of its business. It is not only a report printing software, but also a lab manager that helps track user work, visit patient history and an e-reporting system which saves paper and gives you a fast report delivery, manages kit stock, and gives you an alarm for expiry and short stock.

At PathAI, we are dedicated to enhancing patient outcomes through trustworthy AI-driven technology and meaningful partnerships, with the goal of delivering the most precise diagnoses and effective treatments to patients. Our innovative translational platform, supported by our skilled team of scientists, biostatisticians, and machine learning experts, uncovers and examines new cellular and tissue patterns to identify pathology-related features that yield groundbreaking insights throughout all stages of drug development and various therapeutic domains. By employing dependable and consistent technology, our platforms aim to reduce observer variability and enhance patient selection and stratification, ensuring that the most suitable patients are included in each trial, thereby boosting the likelihood of successful outcomes. Additionally, our technology establishes the most accurate cut points, allowing us to enhance precision and maximize the number of patients who test positive for biomarkers, ultimately contributing to more effective treatments. This commitment to excellence positions us at the forefront of transforming healthcare through advanced analytics and collaboration.

Inspirata is a specialized oncology data and analytics platform built to help cancer programs improve care delivery and operational performance. It leverages AI-driven technology to automate cancer casefinding, data extraction, and reporting with high accuracy. The platform supports compliance with regulatory requirements while significantly reducing manual registry work. Inspirata transforms unstructured clinical data into actionable insights that fuel research and clinical decision-making. Real-time data access helps improve trial accrual and ensures equitable patient access to clinical studies. Patient navigation tools support coordinated care from screening to survivorship. By improving efficiency, Inspirata allows staff to focus on higher-value patient and research activities. The platform integrates seamlessly with major EHR and clinical systems. Trusted by hundreds of hospitals, Inspirata delivers measurable improvements in oncology operations. It helps cancer centers maximize impact while minimizing cost and complexity.

Mamosis offers a cutting-edge AI-powered cancer diagnosis solution that accelerates and improves diagnostic accuracy by analyzing complex medical images and wellness metrics. The platform’s deep learning algorithms, developed with input from clinical experts, identify subtle patterns and anomalies that aid in early cancer detection. Mamosis delivers detailed, easy-to-interpret reports quickly, allowing clinicians to initiate timely interventions. The user-friendly interface streamlines the diagnostic process, enabling secure uploads and fast analysis, saving valuable time in clinical settings. With stringent data encryption and privacy protocols, patient information is protected at every step. Mamosis not only aids medical professionals but also empowers individuals by providing personalized health insights for proactive wellness management. The software integrates seamlessly into existing workflows, enhancing efficiency without disrupting daily operations. By fostering collaboration between AI and human expertise, Mamosis drives more accurate diagnoses and improved patient care.

Labsmart is a comprehensive online management solution designed for pathology laboratories and diagnostic centers. It transforms the conventional offline desktop pathology lab software into a web-based system, enabling real-time information access for both patients and physicians. Employed by over 1,100 labs across India and internationally, Labsmart, as a Software as a Service (SaaS) platform, is experiencing swift growth. Daily, more than 1,500 users rely on this application to manage their business activities efficiently. Labsmart aims to provide a high-quality and cost-effective option specifically tailored for small to medium-sized laboratories, ensuring they can leverage modern technology for improved service delivery. As the demand for efficient lab management continues to rise, Labsmart positions itself as a vital resource in this evolving market.

ACGIL offers a versatile information module designed specifically for pathology labs, enabling the efficient dissemination and recording of data related to all tests conducted within the facility. This system empowers users by allowing them to receive online requests from physicians while also permitting laboratory staff to generate new requests. The pathology lab software is integrated to centralize the entire database and various modules of hospitals, clinics, and medical laboratories into one cohesive interface. Users can effortlessly access and manage information regarding pre-booking, online request receipts, test billing, report delivery, and much more through this streamlined system. Additionally, our clinical lab software plays a crucial role in accurately maintaining records of every test conducted across different disciplines, including Cytology, Hematology, Biochemistry, Serology, and Neurology, ensuring comprehensive data management. Overall, this software solution enhances operational efficiency and improves communication between healthcare providers and laboratories.

Omda Cytodose, an oncology medication management solution from Omda, employs clinically validated protocols along with patient-specific parameters to ensure safer and more effective treatments for individuals battling cancer. This innovative system enhances the quality of care provided to oncology patients by fostering a seamless and collaborative treatment process among healthcare professionals, including doctors, pharmacists, and nurses. Omda Cytodose is designed to support a comprehensive range of adult and pediatric cancers, accommodating various medical treatments such as chemotherapy, immunotherapy, hormone therapy, and additional supportive medications. Initially created by a team of clinicians at one of Norway's premier cancer centers and introduced in 2001, Omda Cytodose has gained widespread adoption across healthcare regions in the Nordic countries, leading to the fulfillment of millions of medication orders. With a robust 15-year history marked by stability, reliability, and safety, the system is meticulously configured with chemotherapy protocols that reflect both national and international guidelines. This ensures that patients receive the most up-to-date treatment options available, further enhancing their chances of successful outcomes.

TrueMedLIS is a cloud-based platform that combines laboratory information management and customer relationship management to streamline and automate various laboratory functions, ranging from sample collection and analysis to data interpretation and reporting, while catering to a wide array of fields such as infectious diseases, COVID-19, cancer genomics, pharmacogenomics (PGx), toxicology, hematology, and other specialized lab areas. By replacing outdated manual methods like paper-based faxes and isolated systems, it facilitates digital order management, provides user-friendly portals for both physicians and patients, and features dedicated interfaces for sales and lab administrators, all with the goal of boosting operational efficiency and minimizing data entry mistakes. Additionally, it seamlessly integrates with pre-existing systems such as billing services and pharmacy benefits management tools, offers real-time analytics along with customizable reporting options in various formats such as Excel and CSV, and is designed with a strong emphasis on security and round-the-clock customer support. This comprehensive approach not only enhances laboratory productivity but also contributes to more accurate and timely patient care outcomes.

VIPER streamlines the process of screening by automating remote patient identification right at the diagnosis stage and ensuring qualified enrollment. By leveraging artificial intelligence, VIPER efficiently matches patients to precision trials during a critical enrollment period by utilizing lab-agnostic genomic data, electronic medical records (EMR), and pathology information tailored to both the patient and the research requirements. The system employs a specialized matching engine that searches for the most suitable clinical trials corresponding to a patient's specific diagnosis at the moment they receive it. Additionally, through seamless workflow integration, VIPER provides real-time alerts regarding a patient’s eligibility for available trials, ensuring the entire care team is informed during this narrow enrollment timeframe. Furthermore, VIPER features interactive dashboards that offer extensive data mining capabilities, allowing for the aggregation of site and study-level patient data to effectively meet study key performance indicators (KPIs). This comprehensive approach not only enhances trial recruitment efficiency but also supports researchers in achieving their goals more effectively.

Pathology Reporting Software stands out as one of the premier Diagnostic Center Management Software options in India, serving also as a Referral Laboratory Software. It is designed to function in both a network-based and standalone model, making it versatile for various operational needs. Additionally, it can serve as diagnostic center billing software, proving its utility across different applications. This fully tested and reliable pathology laboratory software simplifies tasks with features like report generation, lab accounting, and stock entry, thereby enhancing workflow efficiency. The software provides pathology labs with a highly adaptable data module specifically intended for the distribution and recording of information related to all tests conducted in the lab. It is specifically designed to centralize the entire database and modules of clinics, medical laboratories, diagnostic centers, and pathological laboratories into a single unified interface. Information related to test billing, report delivery, and various other functions can be easily accessed and maintained through this comprehensive system, ensuring seamless operation in busy lab environments. Ultimately, this software not only streamlines processes but also significantly improves the accuracy and reliability of lab operations.

Pathology Lab Reporting Software is specifically developed to optimize and oversee the various operations within pathology labs, focusing particularly on the creation and administration of lab reports. These software systems are crafted to address the distinct requirements of pathology laboratories, incorporating functionalities such as: - Streamlined patient registration and billing processes - In-depth creation of lab reports that include thorough diagnostic details - Advanced editing capabilities for personalizing and refining reports - Simplified distribution of reports to both patients and medical professionals - Strong financial management tools to support accounting needs - Detailed user permission settings to protect confidential information Utilizing this type of software allows pathology laboratories to boost their operational productivity, guarantee precision in their reporting, foster better collaboration with healthcare teams, and ultimately enhance the quality of care provided to patients. Not only does this lead to improved workflow, but it also cultivates trust between patients and healthcare providers by ensuring timely and accurate information dissemination.

DeePathology STUDIO offers a user-friendly platform where pathologists and researchers can independently create AI solutions that address critical challenges in the field of Pathology, all from the convenience of their lab laptops. Utilizing the capabilities of DeePathology STUDIO, users can develop "black box" solutions that function as decision support systems for pathologists. We invite you to either download our H. Pylori Detector or participate in validating our TB detector. With a strong history of successful AI projects in pathology, we are equipped to develop tailor-made solutions that align with your specific objectives, ensuring that your unique needs are met effectively. Additionally, our ongoing commitment to innovation empowers users to stay at the forefront of advancements in pathology AI.

Featuring an intuitive touchscreen interface that can also be operated via keyboard and mouse, this system simplifies user interaction. It employs barcoding along with printed unique tracking numbers to provide a robust mechanism for secure tracking, traceability, and management of pathology test samples, requests, results, and reports. Each test set request is assigned a distinct identification barcode or file, ensuring meticulous tracking from the initial scanning of the pathology test form to the ultimate verification and release of results. Additionally, an RFID/EID option is incorporated into the pathology software for enhanced functionality. The platform is built on a sophisticated SQL Client/Server database architecture, which allows users to retrieve information and generate reports through any SQL-compatible applications, such as MS-Excel or MS-Access. The Test Set Database is designed to enable the integration of multiple individual pathology tests into a singularly named Test Set. Moreover, it offers comprehensive user privilege management, granting tailored security settings for each individual user, including options for viewing or editing databases and modifying tests and ranges. This ensures that all users have the appropriate access level required for their specific roles.

Recursion is a leading TechBio innovator using artificial intelligence to radically improve how new medicines are discovered and developed. The company was founded on the idea that images of cells could be used to train AI systems to understand disease biology at scale. By combining data, machine learning models, and powerful computing, Recursion works to overcome the inefficiencies of traditional drug discovery. Its Recursion OS platform connects massive proprietary biological datasets with automated experimentation and AI-driven insights. This approach has produced a growing pipeline of potential therapies for oncology and rare diseases with high unmet medical needs. Recursion has demonstrated significant gains in speed, efficiency, and cost reduction compared to conventional pharmaceutical methods. Strategic partnerships with pharmaceutical companies and technology leaders expand the reach of its platform. The company also collaborates with NVIDIA to power its discovery efforts using BioHive-2, one of the most advanced supercomputers in biopharma. Together, these capabilities position Recursion as a leader in AI-driven drug discovery. Its ultimate goal is to deliver better medicines to patients through precision design and data-driven science.

The Kanteron Platform assimilated a wide array of medical images, digital pathology slides, genomic sequences, and patient information from various modalities, scanners, sequencers, and databases, delivering a comprehensive data toolkit to all teams within hospital networks. It emphasizes pharmacogenomics to avert adverse medication events and facilitates the application of precision medicine at the point of care by integrating data sources on drug-gene interactions that were formerly only accessible in less user-friendly formats, such as tables found in PDF documents. By incorporating major pharmacogenomic databases like PharmGKB, CGI, DGIdb, and OpenTargets, it enables users to customize their queries according to specific gene families, types of interactions, and drug classifications. Additionally, its adaptable AI allows users to select the dataset that best aligns with their specific use case, applying it effectively to pertinent medical images. This robust functionality not only enhances the accuracy of medical insights but also fosters a more personalized approach to patient care.

Smart Laboratory provides an intuitive, cloud-driven pathology software tailored for small to medium-sized laboratories. For the initial six months, our software is available at no cost and comes equipped with a plethora of features aimed at boosting both efficiency and accuracy within your lab operations. Our all-inclusive online pathology management solution facilitates everything from sample tracking to comprehensive reporting, optimizing your workflow. Furthermore, we deliver a budget-friendly alternative with a free version for users looking to manage expenses. The software is designed to ensure that all team members can easily adapt, thereby enhancing overall accessibility. With just a few simple clicks, you can generate accurate pathology reports, significantly improving both the efficiency and precision of your processes while allowing your lab to focus on delivering quality service.

AES Medical's PathoSys® cellular pathology reporting software has been developed in collaboration with consultant pathologists and was the inaugural system to gain recognition from the Royal College of Pathologists (RCPath). By integrating datasets from the Royal College of Pathologists, this software enables standardized reporting and structured data capture, which in turn allows for swift real-time auditing and the export of structured pathology data to authorized third parties. The integration with laboratory systems eliminates the necessity for duplicate entries of demographic and report information while streamlining report distribution. Designed from the ground up, the Pathology Network accommodates multiple laboratories, promoting comprehensive network-wide reporting and auditing capabilities. With its user-friendly interface, the software facilitates rapid real-time searches and audits, effectively shifting the workload balance from data collection to analysis, thereby enhancing the efficiency of clinical audits. This innovative approach not only streamlines processes but also ensures a higher quality of patient care through better data management.

DoraysLab provides cutting-edge software solutions tailored for pathology, radiology, and diagnostic laboratories. Our intuitive Pathology Lab Software, Radiology Lab Software, and Diagnostic Lab Software simplify the management of laboratory tasks. By utilizing our Lab Management Software and LIMS Software, you can consolidate data, automate workflows, and improve the overall efficiency of your laboratory operations. This not only saves time but also contributes to more accurate and reliable lab results.

Oxy Pathology Lab Billing & Reporting Software is an offline, secure platform tailored for pathology laboratories in India to manage billing and reporting efficiently. The software boasts an intuitive and attractive interface that simplifies daily operations while keeping data protected on a local host system. It enables the generation of test reports and PDF documents, with optional interfacing features customized to user requirements. Core functionalities include management of user access via ID and passwords, handling multiple tests with varied rates, referral tracking, and generating detailed MIS reports. Users can personalize report headers and footers, apply digital signatures, and generate unique QR codes for each patient record. The software also includes a master module for adding tests and updating parameters. With round-the-clock digital support, training resources, and timely updates, Oxy supports labs in maintaining accuracy and compliance. This comprehensive solution helps pathology labs optimize workflow and improve patient data management.

CureMetrix harnesses the capabilities of Artificial Intelligence (AI) to enhance technology aimed at bettering disease detection and boosting cancer survival rates on a global scale. Our mission is centered on equipping radiologists with state-of-the-art tools that facilitate their assessment of mammograms, ultimately leading to enhanced clinical and financial results, as well as greater confidence for imaging centers, healthcare systems, and the patients they serve. Initial research involving thousands of images indicates that our innovative algorithm has the potential to decrease false-positive rates, which can help avoid unnecessary follow-up procedures and alleviate patient anxiety. We are committed to creating advanced technology that allows healthcare providers to detect even the smallest changes more swiftly and accurately than ever before. Our image analysis platform is specifically engineered to enhance the evaluation of dense breast tissue through mammography, thereby improving diagnostic accuracy and patient care. As we continue to refine our technology, we remain focused on the impact it can have on the future of medical imaging and patient outcomes.

VSClinical facilitates the clinical analysis of genetic variants in accordance with ACMG and AMP guidelines. Its structured workflow supports adherence to the American College of Medical Genetics (ACMG) standards, which are essential for identifying and categorizing pathogenic variants related to inherited disease risk, cancer susceptibility, and rare disease diagnosis. The combined ACMG/AMP guidelines for variant interpretation establish a framework for scoring variants and categorizing them into one of five classification levels. Implementing these guidelines necessitates a thorough examination of annotations, genomic contexts, and pre-existing clinical insights for each variant. VSClinical streamlines this process by offering a customized workflow that evaluates each relevant criterion and supplies comprehensive bioinformatics, literature references, and clinical knowledgebase evidence to aid in the scoring and interpretation of variants. This innovative approach is designed to enhance the efficiency of variant scientists as they navigate the complexities of variant processing and analysis. Overall, VSClinical stands out as a vital tool for accelerating the understanding and classification of genetic variants in clinical settings.

CADU, a cloud-enabled AI solution created by Odin Vision, is designed to aid in identifying and characterizing dysplasia in individuals with Barrett’s oesophagus during gastroscopy. The system evaluates areas that visually resemble Barrett’s oesophagus and offers insights to help clinicians determine whether the tissue is dysplastic or non-dysplastic. By improving the decision-making process for endoscopists and expediting the examination of the oesophagus, CADU proves to be both time-efficient and cost-effective. Additionally, it functions on a platform that is vendor-neutral, facilitating its use with various endoscopic equipment. The system is CE marked and holds UKCA approval; however, it is not available for commercial sale in the United States. CADU has been adopted in clinical environments, including University College London Hospitals, aiming to enhance the detection of early oesophageal cancer, which can often be difficult to identify due to the subtle nature of initial lesions. Its implementation represents a significant advancement in the early diagnosis of this serious condition, highlighting the importance of technology in modern medicine.

Qure.ai's qLC-Suite is a cutting-edge AI-driven tool aimed at improving the early identification and management of lung nodules, which is crucial for prompt lung cancer intervention. This solution delivers accurate measurements, thorough characterization, and 3D imaging of lung nodules, ensuring that opportunities for early treatment are not overlooked. It is capable of supporting both incidental and targeted screenings by efficiently identifying nodules and calculating their volume with just one click. Moreover, the system monitors volumetric changes over time, providing valuable insights into nodule development. The qLC-Suite is designed to integrate smoothly into current workflows, offering quick analysis and reporting that assist healthcare professionals in their decision-making processes. In addition to its analytical capabilities, it serves as a comprehensive platform for managing lung nodules, facilitating care coordination through intelligent prompts, providing hardware-agnostic image viewing for AI-enhanced chest X-rays and CT scans, enabling seamless sharing of scans across departments, and allowing for tailored notifications for cases of concern. Overall, qLC-Suite represents a significant advancement in lung cancer care, promoting timely interventions that can ultimately save lives.

Diagnosis refers to the process of determining what disease or condition is causing a person's symptoms and test results. DDxHub – Differential diagnosis Hub is a system that distinguishes a specific disease or condition from others with similar symptoms and lab results. DDxHub is a concentrator which holds a lot disease descriptions. DDxHub can be useful when you are trying to find the right diagnosis by comparing multiple diagnoses. You can upload your own disease definition to DDxHub repository, and then share it with other DDxHub users worldwide. You will receive disorder descriptions from other DDxHub users in return. Join thousands of healthcare professionals and patients who already love DDxHub’s differential diagnosis, sync, disorders description sharing solution. DDxHub can be used by medical students in clinical therapeutics as an educational resource.

Carevive provides a cancer care management platform that is integrated with electronic health records (EHR) to improve patient outcomes across the entire cancer treatment process. This innovative platform streamlines treatment planning by gathering patient preferences, evaluating interests in clinical trials, and tackling both physical and psychosocial challenges to enhance decision-making processes. During the active treatment phase, Carevive supports remote monitoring of symptoms through electronic patient-reported outcomes (ePROs), offering personalized symptom management plans and evidence-based pathways that aim to elevate quality of life and minimize hospital admissions. After treatment concludes, the platform continues to monitor patient-reported late effects and organizes essential care, which includes diagnostic assessments to identify new or recurring cancers. Furthermore, Carevive's analytics provide insights into aggregated patient experience data, aiding in ongoing quality enhancement and contributing to practical research in oncology. This comprehensive approach ensures that patients receive holistic support throughout their cancer journey, ultimately leading to better health outcomes.

Aarogya, a comprehensive Hospital Management Information System, includes functionalities like OPD Management, IPD Management, OT Management, TPA Management, Pathology Lab Management, Inventory Management, Finance and Accounting Management, and Blood Bank Management, among others. The system is designed to operate during standard business hours and provides round-the-clock live support. This dependable software solution caters to the needs of mid-sized to large hospitals, diagnostic labs, and polyclinics, ensuring streamlined operations and improved patient care. It also emphasizes efficiency and adaptability, making it a valuable resource in the healthcare sector.

Enhance the Patient Journey by actively engaging, educating, and empowering individuals through improved health communications. Utilize a Patient Engagement Platform to tailor optimal care plans for various medical pathways, such as prostate and breast cancer. Develop a Patient Engagement Pathway that organizes communication strategies in accordance with each care plan's requirements. Streamline the organization of communications by creating or sourcing a variety of supportive materials, including messages, documents, and videos, that correspond to different phases of the care plan. Establish clear communication rules that specify who receives which communications and at what times, ensuring timely delivery of essential information. Integrate new patients into the system effortlessly by matching their specific needs with the appropriate pathway. Finally, centralize all patient-facing communications in one location, allowing for the efficient dissemination of messages, documents, forms, videos, and health widgets. By doing so, healthcare providers can enhance the overall patient experience and foster better health outcomes.